Skip to main content

Teva Pharmaceutical Industries Ltd

TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000818686

In the last 90 days, Teva Pharmaceutical Industries Ltd insiders filed 0 open-market purchases and 8 sales; 675 institutions reported holding it in 13F filings for Q2 2026, worth $24.7B in total; 3 superinvestors hold it, including Greenlight Capital and Duquesne Family Office.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Teva Pharmaceutical Industries Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
8 filings
8 insiders, $17.0M in total
Insiders trading
8
Net value
−$17.0M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Teva Pharmaceutical Industries Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Teva Pharmaceutical Industries Ltd
NameTitleLast reported holdingLast filingFilings, past year
Savage BrianInterim Chief Legal Officer8,500Sep 22, 20264
Mignone RobertoDirector0IndirectSep 22, 20266
Weiss AmirChief Accounting Officer13,071Aug 25, 20267
Satchi-Fainaro RonitDirector111,986Aug 25, 20263
Lippman EvanEVP, Business Development25,591Aug 19, 20263
Zaks Tal ZviDirector73,247Aug 10, 20263
Jover PlacidSee "Remarks"6,774Aug 5, 20263
Hughes Eric ASee "Remarks"134,877Aug 5, 20265
Shields MatthewEVP, Global Operations0Jun 22, 20264
Kalif Eliyahu SharonEVP, Chief Financial Officer65,621Jun 16, 20267
Lieberman Gerald MDirector130,149Jun 8, 20262
Barer Sol JDirector448,011Jun 8, 20262
Crane Rosemary ADirector127,739Jun 8, 20262
Francis Richard DPresident and CEO1,177,529Jun 8, 20266
Nisen PerryDirector119,807Jun 8, 20262
Elstein AmirDirector2,118,455Jun 8, 20262
Lichtenstein ChenDirector19,296Jun 8, 20263
Daniell RichardEVP, Europe Commercial55,755May 7, 20266
Sabag MarkSee "Remarks"80,760May 4, 20267
Fox ChristineEVP, U.S. Commercial63,647May 4, 20265
McAvoy David R.EVP, Chief Legal Officer13,027Sep 9, 20250
Vergis Janet S.Director73,697Jun 9, 20250
Shalev VardaDirector22,504Jun 9, 20250
Grant AngusEVP, Business Development8,848Aug 13, 20240
Conway Vikki LSee "Remarks"0May 15, 20240
Drape EricExecutive VP Global Operations145,915Mar 7, 20240
Bergwerk DovActing Chief Legal Officer96,983Mar 1, 20240
Stark David MatthewExec. VP Chief Legal Officer2,974Mar 8, 20230
Dethlefs SvenEVP, North America Commercial165,381Mar 8, 20230
Shani EliEVP,Global Marketing&Portfolio54,228Mar 7, 20230
Inbar GaliaSee "Remarks"46,011Mar 7, 20230
Schultz KarePresident and CEO1,542,471Nov 2, 20220
Halfon Jean MichelDirector63,707Aug 8, 20220
Peres Nechemia JacobDirector58,765Aug 8, 20220
Fridriksdottir HafrunExecutive VP, Global R&D1,387May 19, 20220
Weil AndrewChief Accounting Officer–Nov 4, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 22, 2026 (view filing)5:01 PM ETSep 184 daysSavage BrianInterim Chief Legal OfficerSSale−7.34K$38.85−$285.2K−46.3%8.50K after3 lots
Sep 22, 2026 (view filing)4:21 PM ETSep 184 daysMignone RobertoDirectorSSale−367.6K$39.06−$14.4M−100.0%0 after
Aug 25, 2026 (view filing)4:05 PM ETAug 214 daysWeiss AmirChief Accounting OfficerSSale−9.45K$37.62−$355.3K−41.9%13.1K after2 lots
Aug 25, 2026 (view filing)4:03 PM ETAug 214 daysSatchi-Fainaro RonitDirectorSSale−415$37.25−$15.5K−0.4%112.0K after
Aug 19, 2026 (view filing)4:00 PM ETAug 172 daysLippman EvanEVP, Business DevelopmentSSale−18.6K$36.57−$680.3K−42.1%25.6K after10b5-1
Aug 10, 2026 (view filing)6:07 AM ETAug 55 daysLateZaks Tal ZviDirectorSSale−17$34.87−$592.710.0%73.2K after
Aug 5, 2026 (view filing)4:04 PM ETAug 32 daysJover PlacidSee "Remarks"SSale−12.8K$34.88−$447.4K−65.4%6.77K after10b5-1
Aug 5, 2026 (view filing)4:02 PM ETAug 32 daysHughes Eric ASee "Remarks"SSale−25.6K$34.88−$892.1K−15.9%134.9K after10b5-1
Jun 22, 2026 (view filing)Jun 184 daysShields MatthewEVP, Global OperationsSSale−9.99K$32.19−$321.5K−100.0%0 after
Jun 16, 2026 (view filing)Jun 115 daysLateKalif Eliyahu SharonEVP, Chief Financial OfficerSSale−106.6K$34.10−$3.63M−61.9%65.6K after10b5-1
Jun 8, 2026 (view filing)Jun 53 daysFrancis Richard DPresident and CEOSSale−6.15K$34.35−$211.4K−0.5%1.18M after10b5-1
Jun 4, 2026 (view filing)Jun 31 dayShields MatthewEVP, Global OperationsSSale−16.2K$32.87−$532.3K−61.9%9.99K after10b5-1
May 18, 2026 (view filing)May 144 daysLippman EvanEVP, Business DevelopmentSSale−41.7K$35.58−$1.48M−48.5%44.2K after2 lots10b5-1
May 18, 2026 (view filing)May 144 daysKalif Eliyahu SharonEVP, Chief Financial OfficerSSale−153.3K$35.61−$5.46M−47.1%172.2K after10b5-1
May 7, 2026 (view filing)May 61 dayWeiss AmirChief Accounting OfficerSSale−10.7K$36.00−$384.4K−34.8%20.0K after
May 7, 2026 (view filing)May 52 daysDaniell RichardEVP, Europe CommercialSSale−30.0K$35.40−$1.06M−35.0%55.8K after
May 4, 2026 (view filing)May 13 daysSabag MarkSee "Remarks"SSale−144.2K$34.99−$5.04M−64.1%80.8K after
May 4, 2026 (view filing)Apr 304 daysFox ChristineEVP, U.S. CommercialSSale−21.3K$35.31−$750.6K−25.0%63.6K after
Mar 19, 2026 (view filing)Mar 172 daysSabag MarkSee "Remarks"SSale−62.1K$30.14−$1.87M−21.6%224.9K after
Mar 9, 2026 (view filing)Mar 54 daysFrancis Richard DPresident and CEOSSale−20.0K$31.67−$634.2K−1.7%1.17M after10b5-1
Mar 9, 2026 (view filing)Mar 54 daysFox ChristineEVP, U.S. CommercialSSale−7.92K$31.67−$251.0K−8.5%84.9K after10b5-1
Mar 9, 2026 (view filing)Mar 54 daysHughes Eric ASee "Remarks"SSale−9.53K$31.67−$301.9K−8.1%107.7K after10b5-1
Mar 9, 2026 (view filing)Mar 54 daysDaniell RichardEVP, Europe CommercialSSale−17.3K$31.67−$547.7K−16.8%85.8K after10b5-1
Mar 9, 2026 (view filing)Mar 54 daysJover PlacidSee "Remarks"SSale−14.2K$31.67−$448.1K−67.6%6.77K after10b5-1
Mar 9, 2026 (view filing)Mar 54 daysSavage BrianInterim Chief Legal OfficerSSale−1.13K$31.67−$35.7K−9.4%10.9K after
Mar 9, 2026 (view filing)Mar 54 daysShields MatthewEVP, Global OperationsSSale−17.3K$31.67−$547.7K−63.4%9.99K after10b5-1
Mar 6, 2026 (view filing)Mar 42 daysFrancis Richard DPresident and CEOSSale−23.4K$32.46−$759.3K−2.0%1.15M after10b5-1
Mar 6, 2026 (view filing)Mar 42 daysDaniell RichardEVP, Europe CommercialSSale−91.3K$32.66−$2.98M−51.6%85.8K after3 lots10b5-1
Mar 6, 2026 (view filing)Mar 42 daysHughes Eric ASee "Remarks"SSale−11.3K$32.46−$366.1K−10.4%97.6K after10b5-1
Mar 6, 2026 (view filing)Mar 42 daysFox ChristineEVP, U.S. CommercialSSale−9.10K$32.46−$295.3K−10.8%75.0K after10b5-1
Mar 6, 2026 (view filing)Mar 42 daysSavage BrianInterim Chief Legal OfficerSSale−2.67K$32.46−$86.8K−24.0%8.46K after2 lots
Mar 5, 2026 (view filing)Mar 32 daysDaniell RichardEVP, Europe CommercialSSale−129.0K$32.36−$4.17M−51.2%123.1K after2 lots10b5-1
Mar 5, 2026 (view filing)Mar 32 daysSavage BrianInterim Chief Legal OfficerSSale−1.27K$32.36−$41.2K−30.3%2.93K after
Mar 5, 2026 (view filing)Mar 32 daysFrancis Richard DPresident and CEOSSale−442.9K$32.36−$14.3M−28.3%1.12M after2 lots10b5-1
Mar 5, 2026 (view filing)Mar 32 daysHughes Eric ASee "Remarks"SSale−80.8K$32.36−$2.61M−48.5%85.6K after2 lots10b5-1
Mar 2, 2026 (view filing)Feb 264 daysKalif Eliyahu SharonEVP, Chief Financial OfficerSSale−345.8K$33.64−$11.6M−85.7%57.5K after10b5-1
Feb 18, 2026 (view filing)Feb 153 daysFrancis Richard DPresident and CEOSSale−447.8K$34.22−$15.3M−42.5%605.8K after2 lots10b5-1
Dec 18, 2025 (view filing)Dec 162 daysWeiss AmirChief Accounting OfficerSSale−12.3K$30.20−$371.5K−68.5%5.65K after
Dec 18, 2025 (view filing)Dec 162 daysMignone RobertoDirectorSSale−77.4K$30.24−$2.34M−17.4%367.6K after
Dec 11, 2025 (view filing)Dec 92 daysDaniell RichardExec. VP, European CommercialSSale−115.5K$28.68−$3.31M−70.5%48.4K after
Dec 11, 2025 (view filing)Dec 92 daysSabag MarkSee "Remarks"SSale−216.9K$28.73−$6.23M−80.4%52.8K after2 lots
Dec 1, 2025 (view filing)Nov 265 daysMignone RobertoDirectorSSale−50.0K$26.03−$1.30M−10.1%445.0K after
Nov 24, 2025 (view filing)Nov 204 daysFox ChristineEVP, Head of U.S. CommercialSSale−28.2K$24.78−$699.5K−30.7%63.6K after10b5-1
Nov 18, 2025 (view filing)Nov 144 daysFox ChristineEVP, Head of U.S. CommercialSSale−30.0K$25.11−$753.3K−51.4%28.4K after
Nov 10, 2025 (view filing)Nov 64 daysMignone RobertoDirectorSSale−200.0K$24.11−$4.82M−28.8%495.0K after
Nov 10, 2025 (view filing)Nov 64 daysWeiss AmirChief Accounting OfficerSSale−12.3K$24.44−$300.6K−40.7%17.9K after
Sep 9, 2025 (view filing)Sep 54 daysMcAvoy David R.EVP, Chief Legal OfficerPPurchase+1.11K$18.86+$21.0K+9.3%13.0K after
Aug 5, 2025 (view filing)Aug 14 daysJover PlacidSee "Remarks"SSale−6.05K$15.16−$91.8K−47.2%6.77K after
Aug 5, 2025 (view filing)Aug 14 daysHughes Eric ASee "Remarks"SSale−52.7K$15.16−$799.6K−100.0%0 after10b5-1
Jun 16, 2025 (view filing)Jun 124 daysKalif Eliyahu SharonEVP, Chief Financial OfficerSSale−55.8K$17.08−$952.6K−12.1%403.3K after10b5-1